{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:17Z","timestamp":1767135197408,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd011874","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000}}],"reference-count":69,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011874.pub2","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T16:55:54Z","timestamp":1508259354000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ocriplasmin for symptomatic vitreomacular adhesion"],"prefix":"10.1002","volume":"2017","author":[{"given":"James E","family":"Neffendorf","sequence":"first","affiliation":[{"name":"King's College Hospital; Department of Ophthalmology; Normanby Building Denmark Hill London UK SE5 9RS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varo","family":"Kirthi","sequence":"additional","affiliation":[{"name":"King's College Hospital; Department of Ophthalmology; Normanby Building Denmark Hill London UK SE5 9RS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Pringle","sequence":"additional","affiliation":[{"name":"King's College Hospital; Department of Ophthalmology; Normanby Building Denmark Hill London UK SE5 9RS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L","family":"Jackson","sequence":"additional","affiliation":[{"name":"King's College Hospital; Department of Ophthalmology; Normanby Building Denmark Hill London UK SE5 9RS"},{"name":"King's College London; School of Medicine; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD011874.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/IAE.0b013e3181e0970a","article-title":"Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial)","volume":"30","author":"Stalmans","year":"2010","journal-title":"Retina"},{"issue":"10","key":"10.1002\/14651858.CD011874.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2016.06.043","article-title":"Results of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial","volume":"123","author":"Dugel","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","article-title":"Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials","volume":"122","author":"Haller","year":"2015","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011874.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011874.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamaophthalmol.2015.1746","article-title":"Improvement in patient-reported visual function after ocriplasmin for vitreomacular adhesion: results of the microplasmin for intravitreous injection-traction release without surgical treatment (MIVI-TRUST) trials","volume":"133","author":"Varma","year":"2015","journal-title":"JAMA Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","article-title":"Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials","volume":"122","author":"Haller","year":"2015","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011874.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011874.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamaophthalmol.2015.1746","article-title":"Improvement in patient-reported visual function after ocriplasmin for vitreomacular adhesion: results of the microplasmin for intravitreous injecion-traction release without surgical treatment (MIVI-TRUST) trials","volume":"133","author":"Varma","year":"2015","journal-title":"JAMA Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011874.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ophtha.2009.11.005","article-title":"A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy","volume":"117","author":"Benz","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011874.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ophtha.2009.03.051","article-title":"Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial","volume":"116","author":"Smet","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2015.03.017","article-title":"Characterization of anatomic and visual function outcomes in patients with full-thickness macular hole in ocriplasmin phase 3 trials","volume":"160","author":"Dugel","year":"2015","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011874.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/02713683.2011.569868","article-title":"Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction","volume":"36","author":"Elbendary","year":"2011","journal-title":"Current Eye Research"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13369","article-title":"Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole","author":"Jackson","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0014|cit14","first-page":"65","article-title":"Ocriplasmin safety overview from clinical trials and postmarketing data","volume":"232","author":"Lanzetta","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0015|cit15","first-page":"66","article-title":"Anatomic and functional responses in clinically relevant subgroups of the MIVI-TRUST clinical trials after ocriplasmin treatment","volume":"232","author":"Lanzetta","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Lescrauwaet B Duchateau L Verstraeten T Jackson TL Long-term visual functioning improvement is associated with resolution of vitreomacular adhesion in subjects with vitreomacular traction, including macular hole treated with intravitreal ocriplasmin: results from the oasis study International Society for Pharmacoeconomics and Outcomes Research 19th Annual European Congress; 2016 Oct 29 - Nov 2; Vienna, Austria","DOI":"10.1016\/j.jval.2016.09.1302"},{"issue":"4","key":"10.1002\/14651858.CD011874.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2014.10.006","article-title":"Safety of intravitreal ocriplasmin for focal vitreomacular adhesion in patients with exudative age-related macular degeneration","volume":"122","author":"Novack","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011874.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/IAE.0000000000000346","article-title":"Factors associated with spontaneous release of vitreomacular traction","volume":"35","author":"Almeida","year":"2015","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD011874.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0161-6420(95)30958-X","article-title":"Treatment of idiopathic macular holes by induced posterior vitreous detachment","volume":"102","author":"Chan","year":"1995","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archopht.118.1.32","article-title":"Papillofoveal traction in macular hole formation: the role of optical coherence tomography","volume":"118","author":"Chauhan","year":"2000","journal-title":"Archives of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD011874.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0161-6420(82)34610-2","article-title":"Vitreoretinal juncture. Synchysis senilis and posterior vitreous detachment","volume":"89","author":"Foos","year":"1982","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011874.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/eye.2008.29","article-title":"Enzymatic vitreous disruption","volume":"22","author":"Gandorfer","year":"2008","journal-title":"Eye"},{"issue":"5","key":"10.1002\/14651858.CD011874.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archopht.1988.01060130683026","article-title":"Idiopathic senile macular hole. Its early stages and pathogenesis","volume":"106","author":"Gass","year":"1988","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011874.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archopht.117.6.744","article-title":"Macular hole formation: new data provided by optical coherence tomography","volume":"117","author":"Gaudric","year":"1999","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011874.pub2-BIB0025|cit25","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0026|cit26","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2014"},{"issue":"6","key":"10.1002\/14651858.CD011874.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/IAE.0000000000000519","article-title":"Safety profile of ocriplasmin for symptomatic vitreomacular adhesion: a comprehensive analysis of premarketing and postmarketing experiences","volume":"35","author":"Hahn","year":"2015","journal-title":"Retina"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","article-title":"Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials","volume":"122","author":"Haller","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/eye.2016.195","article-title":"Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons","volume":"31","author":"Haynes","year":"2017","journal-title":"Eye"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0030|cit30","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0031|cit31","unstructured":"Higgins JP Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD011874.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/bjo.79.6.517","article-title":"Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes","volume":"79","author":"Hikichi","year":"1995","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011874.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-9394(02)01944-X","article-title":"Mapping posterior vitreous detachment by optical coherence tomography in eyes with idiopathic macular hole","volume":"135","author":"Ito","year":"2003","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD011874.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/IAE.0b013e31829232fd","article-title":"Symptomatic vitreomacular adhesion","volume":"33","author":"Jackson","year":"2013","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD011874.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/IAE.0b013e31828991d6","article-title":"Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis","volume":"33","author":"Jackson","year":"2013","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD011874.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/eye.2013.12","article-title":"United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: report 1; case mix, complications, and cataract","volume":"27","author":"Jackson","year":"2013","journal-title":"Eye"},{"issue":"8","key":"10.1002\/14651858.CD011874.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3928\/23258160-20160808-04","article-title":"Baseline predictors of vitreomacular adhesion\/traction resolution following an intravitreal injection of ocriplasmin","volume":"47","author":"Jackson","year":"2016","journal-title":"Ophthalmic Surgery, Lasers and Imaging Retina"},{"issue":"3","key":"10.1002\/14651858.CD011874.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajo.2009.11.022","article-title":"Posterior vitreous detachment: evolution and complications of its early stages","volume":"149","author":"Johnson","year":"2010","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011874.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40123-016-0062-6","article-title":"Ocriplasmin for treatment of vitreomacular traction: an update","volume":"5","author":"Khan","year":"2016","journal-title":"Ophthalmology and Therapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011874.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1097\/IAE.0b013e31825bc593","article-title":"Ocriplasmin for pharmacologic vitreolysis","volume":"32","author":"Kuppermann","year":"2012","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD011874.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1034\/j.1600-0420.2002.800605.x","article-title":"Macular holes: classification, epidemiology, natural history and treatment","volume":"80","author":"Cour","year":"2002","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD011874.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0161-6420(98)99027-3","article-title":"Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes","volume":"105","author":"Margherio","year":"1998","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011874.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00006982-199515030-00002","article-title":"Vitrectomy for vitreomacular traction syndrome with macular detachment","volume":"15","author":"Melberg","year":"1995","journal-title":"Retina"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ophtha.2006.07.001","article-title":"Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment","volume":"114","author":"Mori","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011874.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ICB.0000000000000260","article-title":"Widespread macular neurosensory detachment after ocriplasmin intravitreal injection","volume":"10","author":"Neffendorf","year":"2016","journal-title":"Retinal Cases and Brief Reports"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0046|cit46","unstructured":"National Institute for Health and Care Excellence Ocriplasmin for treating vitreomacular traction. NICE technology appraisal guidance 297 www.nice.org.uk\/guidance\/ta297"},{"issue":"5","key":"10.1002\/14651858.CD011874.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10384-014-0333-5","article-title":"Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration","volume":"58","author":"Nomura","year":"2014","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011874.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/IAE.0000000000001371","article-title":"Impact of vitreoretinal interface architecture on successful vitreomacular traction resolution in eyes scheduled for intravitreal ocriplasmin therapy","volume":"37","author":"Paul","year":"2017","journal-title":"Retina"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0049|cit49","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"2","key":"10.1002\/14651858.CD011874.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajo.2012.08.018","article-title":"Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction","volume":"155","author":"Rodrigues","year":"2013","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/112067210601600122","article-title":"Use of autologous plasmin during vitrectomy for diabetic maculopathy","volume":"16","author":"Sakuma","year":"2006","journal-title":"European Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011874.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.survophthal.2012.01.011","article-title":"Vitreomacular adhesion and neovascular age-related macular degeneration","volume":"57","author":"Simpson","year":"2012","journal-title":"Survey of Ophthalmology"},{"key":"10.1002\/14651858.CD011874.pub2-BIB0053|cit53","unstructured":"JETREA 0.5 mg\/0.2 ml concentrate for solution for injection www.medicines.org.uk\/emc\/medicine\/27585"},{"issue":"9","key":"10.1002\/14651858.CD011874.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/IAE.0b013e31817b6b0f","article-title":"Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes","volume":"28","author":"Sonmez","year":"2008","journal-title":"Retina"},{"issue":"7","key":"10.1002\/14651858.CD011874.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/IAE.0b013e3181e0970a","article-title":"Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial)","volume":"30","author":"Stalmans","year":"2010","journal-title":"Retina"},{"issue":"7","key":"10.1002\/14651858.CD011874.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011874.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/eye.2013.212","article-title":"Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment","volume":"27","author":"Steel","year":"2013","journal-title":"Eye"},{"issue":"9","key":"10.1002\/14651858.CD011874.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bjo.85.9.1092","article-title":"Optical coherence tomography of the vitreoretinal interface in macular hole formation","volume":"85","author":"Tanner","year":"2001","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011874.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10384-013-0302-4","article-title":"Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion","volume":"58","author":"Terao","year":"2014","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011874.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ajo.2014.01.011","article-title":"Spontaneous release of vitreomacular traction demonstrated by spectral-domain optical coherence tomography","volume":"157","author":"Theodossiadis","year":"2014","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011874.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archopht.119.10.1475","article-title":"Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography","volume":"119","author":"Uchino","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011874.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamaophthalmol.2015.1746","article-title":"Improvement in patient-reported visual function after ocriplasmin for vitreomacular adhesion: results of the microplasmin for intravitreous injecion-traction release without surgical treatment (MIVI-TRUST) trials","volume":"133","author":"Varma","year":"2015","journal-title":"JAMA Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011874.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajo.2014.04.028","article-title":"Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration","volume":"158","author":"Waldstein","year":"2014","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011874.pub2-BIB0064|cit64","first-page":"44","article-title":"Spontaneous resolution of vitreomacular traction syndrome","volume":"106","author":"Weinard","year":"2009","journal-title":"Ophthalmologe"},{"issue":"2","key":"10.1002\/14651858.CD011874.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archopht.1979.01020010173020","article-title":"Scaling of visual acuity measurements","volume":"97","author":"Westheimer","year":"1979","journal-title":"Archives of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011874.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0161-6420(01)00720-5","article-title":"Autologous plasmin enzyme in the surgical management of diabetic retinopathy","volume":"108","author":"Williams","year":"2001","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011874.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10792-013-9884-6","article-title":"Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities","volume":"34","author":"Yoon","year":"2014","journal-title":"International Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011874.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcjo.2014.12.003","article-title":"Natural course of vitreomacular traction syndrome observed by spectral-domain optical coherence tomography","volume":"50","author":"Zhang","year":"2015","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011874.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011874","article-title":"Ocriplasmin for symptomatic vitreomacular adhesion","author":"Neffendorf","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011874.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T05:12:13Z","timestamp":1688533933000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011874.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011874.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]}}}